|Name of Journal||World Journal of Pharmacology|
|Title Abbreviation||World J Pharmacol|
|Background||World Journal of Pharmacology (WJP, World J Pharmacol) is a high-quality, online, open-access, single-blind peer-reviewed journal that is published by the Baishideng Publishing Group. Accepting both solicited and unsolicited manuscripts, the WJP mainly publishes high-quality clinical research articles to improve the academic influence of authors, help cultivate distinguished pharmacologists, and promote the development of pharmacology. The types of articles published in the WJP include Editorial, Opinion Review, Frontier, Review, Minireview, Topic Highlight, Clinical Research, Systematic Review, Meta-analysis, Evidence-based Medicine, Advances in Diagnosis, Advances in Treatment, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report.|
The primary aim of the WJP is to provide scholars and readers from various fields of pharmacology with a platform to publish high-quality clinical research articles and communicate their research findings online. In order to ensure the quality, timeliness, fairness, and transparency of manuscript publication, the WJP has implemented a variety of measures as follows:
First, authors must prepare their articles according to the appropriate international publication recommendations, including the STROBE Statement, CONSORT 2010 Statement, PRISMA 2009 Checklist, and CARE Checklist – 2016: Information for writing a case report.
Second, articles published in the WJP must undergo rigorous cross-international peer review, where peer reviewers and authors come from different countries and independent peer reviewers are chosen by the editorial office, not by authors, to ensure the fairness of peer review.
Third, designation of co-first authors or co-corresponding authors is not permitted.
Fourth, the WJP accepts a manuscript based mainly on its novelty, innovativeness, data accuracy, picture reliability, clear language expression, and ethical requirements. Of note, peer reviewers will complete the peer review within 7 days, providing a comprehensive evaluation of the scientific and linguistic quality of the manuscript.
Fifth, BPG adopts a 7-day publishing management policy. This means that each step of the publishing process, including manuscript preview, peer review, manuscript revision by authors, final acceptance, language editing, and production and release, must be completed within 7 days.Finally, the peer review report, author’s response to the peer review report, biostatistics review certificate, copyright license agreement, institutional ethics committee approval document, informed consent, conflict-of-interest statement, CrossCheck detection report, authors’ personal ORCID numbers, funding information, language editing certificate, and other relevant documents will be published online along with the article to ensure that the publishing process is open and transparent.
|Scope||The WJP mainly publishes research results and findings obtained in the field of pharmacology covering a wide range of topics including antineoplastic protocols, chelation therapy, chemoprevention, chemoradiotherapy, adjuvant chemotherapy, consolidation chemotherapy, drug administration routes, drug administration schedule, drug delivery systems, drug dosage calculations, drug prescriptions, combination drug therapy, computer-assisted drug therapy, electrochemotherapy, enema, enzyme therapy, fluid therapy, home infusion therapy, hormone replacement therapy, inappropriate prescribing, induction chemotherapy, maintenance chemotherapy, medication errors, molecular targeted therapy, opiate substitution treatment, orthomolecular therapy, photochemotherapy, pleurodesis, polypharmacy, premedication, prescription drug misuse, sclerotherapy, self-administration, self-medication, and thrombolytic therapy.|
|Open Access||Open access|
|Indexing/Abstracting||China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (CSTJ), and Superstar Journals Database.|
|Journal Metrics||There is currently no impact factor.|
|Article Processing Charge||Article processing charge|
|Editors-in-Chief||Nam Deuk Kim|
|Research Domain||Pharmacology and Pharmacy|
|Article Reprints||Article reprints|
|Help Desk||Help desk|
|Special Statement||Special statement|
|Copyright ©||© 2004-2019 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA|
|Contact Us||Contact us|